Ledger.Open graph →
SEC Form D · filed June 29, 2018

Attune Pharmaceuticals, Inc

Offering
$23.6M
Sold
$23.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Roderick Wong · NEW YORK, NYDirectorAdam Tomasi · SAN CARLOS, CADirectorAndrew Mcdonald · NEW YORK, NYExec · DirectorJason Bablak · NEW YORK, NYExecAdam Tomasi · SAN CARLOS, CADirectorRoderick Wong · NEW YORK, NYDirectorAndrew Mcdonald · NEW YORK, NYExec · DirectorJason Bablak · NEW YORK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗